pharmaceuticals
pharmaceuticals Articles
Clementia Pharmaceuticals intends to price more than 7 million shares in a range that will result in an initial public offering valued up to more than $123 million.
Published:
Last Updated:
Reata Pharmaceuticals saw its shares make an incredible gain to kick off the week after it reported initial data from its mid-stage trial evaluating bardoxolone in patients with chronic kidney...
Published:
Last Updated:
Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the pack with Eli Lilly and Co. (NYSE: LLY) in a close second....
Published:
Last Updated:
Shares of Vertex Pharmaceuticals shot up after the company announced dramatic results from its early and mid-stage trials in cystic fibrosis. The stock pushed to an all-time high on the back of these...
Published:
Last Updated:
A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the report's top picks: AbbVie, Eli Lilly, Merck, and Shire.
Published:
Last Updated:
Sienna Biopharmaceuticals filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company expects to price its 4.33 million shares...
Published:
Last Updated:
The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Last Updated:
The biotech industry has made a splash in 2017, outperforming practically all the broad markets. With this incredible display, it's no wonder that investor interest in this particular industry has...
Published:
Last Updated:
Shares of Arena Pharmaceuticals saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial in patients with pulmonary arterial hypertension.
Published:
Last Updated:
Kala Pharmaceuticals intends to price 6 million shares in the range of $14 to $16 apiece in an initial public offering valued up to more than $110 million.
Published:
Last Updated:
In an incredible move on Friday, the FDA approved Endari for the treatment of patients age five and older with sickle cell disease to reduce severe complications that are common with the blood...
Published:
Last Updated:
Conatus Pharmaceuticals saw its shares make a handy gain on Friday after the firm announced an exclusive license agreement with Novartis.
Published:
Last Updated:
Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the combination of binimetinib and encorafenib for the treatment of patients with melanoma.
Published:
Last Updated:
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and added some color.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks shrank.
Published:
Last Updated: